Cargando…
Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breas...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140094/ https://www.ncbi.nlm.nih.gov/pubmed/35626053 http://dx.doi.org/10.3390/cancers14102450 |
_version_ | 1784715014747193344 |
---|---|
author | Duan, Suzann Buxton, Iain L. O. |
author_facet | Duan, Suzann Buxton, Iain L. O. |
author_sort | Duan, Suzann |
collection | PubMed |
description | SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breast cancer remains an abysmal 27%. To better inform future directions for managing this disease, it is helpful to examine the evolution of cancer research, from foundational concepts to therapies and their pitfalls. This review aims to provide a rich overview of the history of breast cancer therapies spanning antiquity to the modern era, concluding with the rapid advancements in immunotherapies and our eventual progression towards personalized medicine. ABSTRACT: An examination of the origins of medical approaches to breast cancer marks this disease as one of the most difficult to manage. As the early identification, diagnosis and treatment of breast cancer evolve, we will move to a time when each patient and their cancer can be assessed to determine unique patient-specific (personalized) approaches to therapy. Humans have attempted to manage breast cancer for millennia. Even today, the disease claims thousands of lives each year. In light of the increasingly sophisticated understanding of cancer diagnosis and treatment, together with our ultimate failure to offer a cure in the most difficult cases, it is instructive to reflect on the beginnings of our understanding. |
format | Online Article Text |
id | pubmed-9140094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91400942022-05-28 Evolution of Medical Approaches and Prominent Therapies in Breast Cancer Duan, Suzann Buxton, Iain L. O. Cancers (Basel) Review SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breast cancer remains an abysmal 27%. To better inform future directions for managing this disease, it is helpful to examine the evolution of cancer research, from foundational concepts to therapies and their pitfalls. This review aims to provide a rich overview of the history of breast cancer therapies spanning antiquity to the modern era, concluding with the rapid advancements in immunotherapies and our eventual progression towards personalized medicine. ABSTRACT: An examination of the origins of medical approaches to breast cancer marks this disease as one of the most difficult to manage. As the early identification, diagnosis and treatment of breast cancer evolve, we will move to a time when each patient and their cancer can be assessed to determine unique patient-specific (personalized) approaches to therapy. Humans have attempted to manage breast cancer for millennia. Even today, the disease claims thousands of lives each year. In light of the increasingly sophisticated understanding of cancer diagnosis and treatment, together with our ultimate failure to offer a cure in the most difficult cases, it is instructive to reflect on the beginnings of our understanding. MDPI 2022-05-16 /pmc/articles/PMC9140094/ /pubmed/35626053 http://dx.doi.org/10.3390/cancers14102450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Duan, Suzann Buxton, Iain L. O. Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title | Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title_full | Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title_fullStr | Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title_full_unstemmed | Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title_short | Evolution of Medical Approaches and Prominent Therapies in Breast Cancer |
title_sort | evolution of medical approaches and prominent therapies in breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140094/ https://www.ncbi.nlm.nih.gov/pubmed/35626053 http://dx.doi.org/10.3390/cancers14102450 |
work_keys_str_mv | AT duansuzann evolutionofmedicalapproachesandprominenttherapiesinbreastcancer AT buxtoniainlo evolutionofmedicalapproachesandprominenttherapiesinbreastcancer |